VIA
ITOS

Virtus Investment Advisers’s iTeos Therapeutics ITOS Stock Holding History

Virtus Investment Advisers’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,422
Closed -$93.9K – 455
2025
Q2 		$93.9K Sell
9,422
-11,241
-54% -$90.6K 0.03% 358
2025
Q1 		$123K Buy
+20,663
New +$152K 0.03% 389

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus Investment Advisers's ITOS Position: Q3 2025 in Review

Virtus Investment Advisers sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 9,422 shares — an estimated $93.9K sold.

Virtus Investment Advisers first reported a position in ITOS in Q1 2025 and held it in 2 quarters. The position peaked at $123K in Q1 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Virtus Investment Advisers reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 9,422 iTeos Therapeutics shares in Q3 2025, an estimated $93.9K.
  • Virtus Investment Advisers first reported a position in iTeos Therapeutics in Q1 2025 and held it in 2 quarters.
  • Virtus Investment Advisers's iTeos Therapeutics position peaked at $123K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Virtus Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.